The panel discussed symptoms of narcolepsy and idiopathic hypersomnia beyond sleepiness. The discussion focused on the full spectrum of symptoms which are the most bothersome for patients and the impact of those symptoms on patient function. The experts discussed the lexicon used by their patients and the mitigation strategies of bringing more focus to the full spectrum of symptoms to everyday clinical practice.
This opportunity was made possible by the Sleep Research Society Foundation.
Supported by: Takeda Pharmaceutical
Chair: Alon Y. Avidan MD, MPH
Panelists:
Christian Baumann, PhD
Bruce Corser, MD
Yves Dauvilliers, MD, PhD
Nancy Foldvary-Schaefer, DO, MS
Patricia Franco, MD, PhD
Suresh Kotagal, MBBS, FAASM
Markku Partinen, MD, PhD, FAAN
David T. Plante, MD, PhD
Luis E. Ortiz, MD
Chad M. Ruoff, MD
David B. Rye, MD, PhD
Additional Webinar Materials
- “I feel my arm shaking”: partial cataplexy mistaken for drug-resistant focal epilepsy
- Assessing sleepiness and cataplexy in children and adolescents with narcolepsy: a review of current patient-reported measures
- Autonomic dysfunction in idiopathic hypersomnia: an overlooked association and potential management
- Brain Fog Scale (BFS): Scale development and validation
- Cataplexy
- Clinical considerations for the diagnosis of idiopathic hypersomnia
- Reevaluating spells initially identified as cataplexy
- Dysautonomia in Narcolepsy: Evidence by Questionnaire Assessment
- Idiopathic Hypersomnia Severity Scale (IHSS)
- Agreement analysis of sleep patterns between self-reported questionnaires and actigraphy in adults
- Sleep inertia measurement with the psychomotor vigilance task in idiopathic hypersomnia
- What is brain fog?
